A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer
- 1 September 1993
- Vol. 72 (5) , 1564-1572
- https://doi.org/10.1002/1097-0142(19930901)72:5<1564::aid-cncr2820720513>3.0.co;2-a
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Chemotherapy and Survival in Non-Small Cell Lung CancerChest, 1991
- Chemotherapy for Non-Small Cell Lung CancerChest, 1991
- Chemotherapy and Survival of Patients with Non-Small Cell Lung CancerChest, 1991
- Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancerCancer, 1991
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Chapter 1 The first international workshop on small cell lung cancer antigensLung Cancer, 1988
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Progress in chemotherapy of non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982